NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000018144

Registered date:01/07/2015

A study for the new regimen of pilocarpine hydrochloride in patients with xerostomia

Basic Information

Recruitment status Pending
Health condition(s) or Problem(s) studiedxerostomia
Date of first enrollment2015/07/13
Target sample size40
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)After pilocaripine hydrochloride (5mg, increscent) is orally administered three times daily for 8 weeks, the granules of pilocaripine hydrochloride (0.5%) as mouthwash is administered three times daily for 8 weeks. After the granules of pilocaripine hydrochloride (0.5%) as mouthwash is administered three times daily for 8 weeks, pilocaripine hydrochloride (5mg, increscent) is orally administered three times daily for 8 weeks.

Outcome(s)

Primary Outcome1)dry mouth questionnaire with the visual analog scale (VAS) 2)total amount of saliva production
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteriapatients who have contraindication to pilocarpine hydrochloride.

Related Information

Contact

public contact
Name Yoko Kawase-Koga
Address 6-7-1, Nishishinjuku, Shinjukuku, Tokyo160-0023, Japan Japan
Telephone 81-3-3342-6111
E-mail kogay@tokyo-med.ac.jp
Affiliation Tokyo Medical University Department of Oral and Maxillofacial Surgery
scientific contact
Name Yoko Kawase-Koga
Address 6-7-1, Nishishinjuku, Shinjukuku, Tokyo160-0023, Japan Japan
Telephone 81-3-3342-6111
E-mail kogay@tokyo-med.ac.jp
Affiliation Tokyo Medical University Department of Oral and Maxillofacial Surgery